ART-Pterostilbene

Not Applicable

Recruiting

• Conditions: Infertility; infertility

• Registration Number: JPRN-jRCTs031220638
• Lead Sponsor: Kawamura Kazuhiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 460

Inclusion Criteria

(1) Infertile female patients undergoing in vitro fertilization.
(2) Patients aged 40 years or older at the time of informed consent .
(3) Patients attending the outpatient clinic of a collaborating study site.
(4) Patients who have the ability to consent and are able to obtain written consent by their own volition.
(5) Patients judged by the investigator (co-investigator) to be able to appropriately evaluate the efficacy and safety of this study with considering the inclusion and exclusion criteria.

Exclusion Criteria

(1) Patients taking supplements other than vitamin D, folic acid, or iron within one menstrual cycle before the start of the study.
(2) Patients where the possible causes of infertility include diabetes mellitus, polycystic ovary, or a partner with severe spermatogenic dysfunction.
(3) Patients who have received reproductively toxic chemotherapy or radiotherapy.
(4) Patients with recurrent implantation failure.
(5) Unmarried patients who wish to freeze their eggs.
(6) Patients who have participated in this study in the past.
(7) Patients with an allergy to resveratrols and dextrin (starch).
(8) Patients with a menstrual cycle of 3 weeks or less or 5 weeks or more.
(9)Patients who are considered inappropriate for participation in the study by the investigator or subinvestigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified